179 related articles for article (PubMed ID: 28625466)
1. First Pediatric Patient With Neuromyelitis Optica and Sjögren Syndrome Successfully Treated With Tocilizumab.
Marino A; Narula S; Lerman MA
Pediatr Neurol; 2017 Aug; 73():e5-e6. PubMed ID: 28625466
[No Abstract] [Full Text] [Related]
2. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report.
Komai T; Shoda H; Yamaguchi K; Sakurai K; Shibuya M; Kubo K; Takahashi T; Fujio K; Yamamoto K
Mod Rheumatol; 2016; 26(2):294-6. PubMed ID: 24313919
[TBL] [Abstract][Full Text] [Related]
3. Primary Sjögren Syndrome in a Child with a Neuromyelitis Optica Spectrum Disorder.
Kornitzer JM; Kimura Y; Janow GL
J Rheumatol; 2016 Jun; 43(6):1260-1. PubMed ID: 27252507
[No Abstract] [Full Text] [Related]
4. Neuromyelitis optica spectrum disorder complicated with Sjögren's syndrome: first pediatric case responsive to mycophenolate mofetil treatment.
Fang GL; Fang W; Zheng Y; Zhang YX
Acta Neurol Belg; 2021 Aug; 121(4):1065-1067. PubMed ID: 33136271
[No Abstract] [Full Text] [Related]
5. Tocilizumab for refractory organising pneumonia associated with Sjögren's disease.
Justet A; Ottaviani S; Dieudé P; Taillé C
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976199
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren's syndrome: case-report and literature review.
Torgashina AV; Vasilyev VI
Ter Arkh; 2018 May; 90(5):76-80. PubMed ID: 30701893
[TBL] [Abstract][Full Text] [Related]
7. Reversible stenosis of large cerebral arteries in a patient with combined Sjögren's syndrome and neuromyelitis optica spectrum disorder.
Ii Y; Shindo A; Sasaki R; Naito Y; Tanaka K; Kuzuhara S
Rheumatol Int; 2008 Oct; 28(12):1277-80. PubMed ID: 18493764
[TBL] [Abstract][Full Text] [Related]
8. A case of pathology-proven neuromyelitis optica spectrum disorder with Sjögren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion.
Sawada J; Orimoto R; Misu T; Katayama T; Aizawa H; Asanome A; Takahashi K; Saito T; Anei R; Kamada K; Miyokawa N; Takahashi T; Fujihara K; Hasebe N
Mult Scler; 2014 Sep; 20(10):1413-6. PubMed ID: 24986696
[TBL] [Abstract][Full Text] [Related]
9. [Primary Sjögren's syndrome and neuromyelitis optica].
Chourkani N; El Moutawakil B; Sibai M; Bourezgui M; Rafai MA; Slassi I
Rev Med Interne; 2010 Sep; 31(9):e13-5. PubMed ID: 20554086
[TBL] [Abstract][Full Text] [Related]
10. Steroid-responsive Devic's variant in Sjögren's syndrome.
Mochizuki A; Hayashi A; Hisahara S; Shoji S
Neurology; 2000 Mar; 54(6):1391-2. PubMed ID: 10746622
[No Abstract] [Full Text] [Related]
11. Sjögren's syndrome associated with Crohn's disease successfully treated with adalimumab.
Tursi A
J Crohns Colitis; 2012 Mar; 6(2):263. PubMed ID: 22325185
[No Abstract] [Full Text] [Related]
12. First report of improvement of coeliac disease in a patient with Sjögren's syndrome treated with rituximab.
Nikiphorou E; Hall FC
Rheumatology (Oxford); 2014 Oct; 53(10):1906-7. PubMed ID: 24729401
[No Abstract] [Full Text] [Related]
13. Patient with neuromyelitis optica spectrum disorder combined with Sjögren's syndrome relapse free following tacrolimus treatment.
Zheng X; Zhang X; Liu X; Mu W; Yang W; Liu Y; Ge P; Li H
Intern Med; 2014; 53(20):2377-80. PubMed ID: 25318807
[TBL] [Abstract][Full Text] [Related]
14. Syringomyelia-like syndrome in neuromyelitis optica spectrum disorder complicated with Sjogren's syndrome: a case report.
Li X; Lu Z; Wang Y
BMC Neurol; 2018 Oct; 18(1):168. PubMed ID: 30301458
[TBL] [Abstract][Full Text] [Related]
15. Complete remission of protein-losing gastroenteropathy associated with Sjögren's syndrome by B cell-targeted therapy with rituximab.
Uraoka Y; Tanigawa T; Watanabe K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Watanabe T; Fujiwara Y; Arakawa T
Am J Gastroenterol; 2012 Aug; 107(8):1266-8. PubMed ID: 22859008
[No Abstract] [Full Text] [Related]
16. Vasculitis in Sjögren's Syndrome.
Scofield RH
Curr Rheumatol Rep; 2011 Dec; 13(6):482-8. PubMed ID: 21870104
[TBL] [Abstract][Full Text] [Related]
17. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndrome.
Kahlenberg JM
Semin Arthritis Rheum; 2011 Feb; 40(4):343-8. PubMed ID: 20655576
[TBL] [Abstract][Full Text] [Related]
18. Longitudinally extensive transverse myelitis.
Tobin WO; Weinshenker BG; Lucchinetti CF
Curr Opin Neurol; 2014 Jun; 27(3):279-89. PubMed ID: 24792338
[TBL] [Abstract][Full Text] [Related]
19. [The clinical characteristics of primary Sjögren syndrome with neuromyelitis optica].
Qiao L; Luo Y; Zhang LL; Zhao LD; Wang Q; Xu Y; Zhao Y
Zhonghua Nei Ke Za Zhi; 2013 Sep; 52(9):745-8. PubMed ID: 24314164
[TBL] [Abstract][Full Text] [Related]
20. Acquired factor VIII inhibitor in Sjögren's syndrome.
Vintimilla M; Joseph A; Ranganathan P
Arthritis Care Res (Hoboken); 2010 Jul; 62(7):1047-50. PubMed ID: 20589701
[No Abstract] [Full Text] [Related]
[Next] [New Search]
